Molecular imaging of neuroendocrine tumors optimizes radiotherapy dose

Aggressive neuroendocrine cancer is something of a dark horse -- a rare, elusive and persevering force linked to discouraging long-term survival rates. Researchers are presenting a molecular imaging technique that allows oncologists to set patients' radiotherapy doses right at that critical limit of delivering the most powerful kill to neuroendocrine tumors (NETs) while protecting vulnerable vital organs.